Loading…
Stem Cell Therapeutic and Research Reauthorization Act of 2010
Legislative Progress
Introduced
August 9, 2010
Latest Action
September 28, 2010
Primary Sponsor
C. W. Bill YoungRepublican(FL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
78pct
50d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2010 · fourth_quarter · Health Issues
H.R. 6081 & S. 3751, The Stem Cell Therapeutic & Research Act of 2010.
Client expense: Not reported · Firm income: $30,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Comparative Effectiveness Research Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081) Use of Cesium-137 Chloride (CsCl) sources in biomedical research
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
2010 · fourth_quarter · Health Issues
Healthcare for cancer patients , C.W. Bill Young Transplatation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009, H.R.6081 and S.3751, The Stem Cell Therapeutic & Research Act 2010
Client expense: $103,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
H.R.6081: Stem Cell Therapeutic and Research Reauthorization Act of 2010 S.3751: Stem Cell Therapeutic and Research Reauthorization Act of 2010
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medical/Disease Research/Clinical Labs
Bone Marrow Failure Disease Research and Treatment Act (H.R. 1230) General Hematology Public Health and Research Issues Hematology and Oncology Drug Research and Approval Issues Embryonic Stem Cell Research Issues Sickle Cell Disease Public Access Thrombosis Electronic Health Records (EHR) Hematology/Oncology treatment Issues Clinical Trials Insurance Coverage Resolution Expressing Support for Designation of September 2010 as Blood Cancer Awareness Month (H.Res. 1433) Comparative Effectiveness Research Proposed Revisions to NIH COI Policy Stem Cell Research Advancement Act (H.R. 4808 / S. 3766) Stem Cell Therapeutic and Research Reauthorization Act of 2010 (S. 3751 / H.R. 6081)
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2010 · third_quarter · Health Issues
Healthcare for cancer patients , C.W. Bill Young Transplatation Program, National Cord Blood Inventory, H.R. 1230 Bone Marrow Failure Disease Research and Treatment Act of 2009, S 488, H.R. 716, Access to Cancer Clinical Trials Act of 2009, SGW 121 access to all healthcare bill, SRES 205/HCR 150 African American Bone Marrow Awareness month, Americans Affordable Health Choices Act of 2009, American Healthy Future Act of 2009, H.R.6081 and S.3751, The Stem Cell Therapeutic & Research Act 2010 HR 1230
Client expense: $98,624 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R. 6081 & S. 3751, The Stem Cell Therapeutic & Research Act of 2010.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R.6081: Stem Cell Therapeutic and Research Reauthorization Act of 2010 S.3751: Stem Cell Therapeutic and Research Reauthorization Act of 2010
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
| Democratic |
| CT |
| James Oberstar | Democratic | MN |
| Jesse L. Jackson Jr. | Democratic | IL |
| Keith Ellison | Democratic | MN |
| Laura Richardson | Democratic | CA |
| Lois Capps | Democratic | CA |
| Steve Cohen | Democratic | TN |